Identification of a novel cell death receptor mediating IGFBP-3-induced anti-tumor effects in breast and prostate cancer - sprookjes - yvandenbroek - TriplyDB

Identification of a novel cell death receptor mediating IGFBP-3-induced anti-tumor effects in breast and prostate cancer

Identification of a novel cell death receptor mediating IGFBP-3-induced anti-tumor effects in breast and prostate cancer

http://www.wikidata.org/entity/Q24604176

about

Understanding the Key to Targeting the IGF Axis in Cancer: A Biomarker Assessment An ocular view of the IGF-IGFBP system IGF binding proteins in cancer: mechanistic and clinical insights Does milk intake promote prostate cancer initiation or progression via effects on insulin-like growth factors (IGFs)? A systematic review and meta-analysis Regulation of retinal endothelial cell apoptosis through activation of the IGFBP-3 receptor.Low expression levels of insulin-like growth factor binding protein-3 are correlated with poor prognosis for patients with hepatocellular carcinoma Targeting insulin-like growth factor-I and insulin-like growth factor-binding protein-3 signaling pathways. A novel therapeutic approach for asthma The proliferating role of insulin and insulin-like growth factors in cancer.Activation of various downstream signaling molecules by IGFBP-3.Protection of blood retinal barrier and systemic vasculature by insulin-like growth factor binding protein-3.IGFBP-3 inhibits cytokine-induced insulin resistance and early manifestations of atherosclerosis Novel protective properties of IGFBP-3 result in enhanced pericyte ensheathment, reduced microglial activation, increased microglial apoptosis, and neuronal protection after ischemic retinal injury.Insulin-like growth factor-binding protein-3 (IGFBP-3) blocks the effects of asthma by negatively regulating NF-κB signaling through IGFBP-3R-mediated activation of caspases.The link between the metabolic syndrome and cancer.Antiangiogenic antitumor activities of IGFBP-3 are mediated by IGF-independent suppression of Erk1/2 activation and Egr-1-mediated transcriptional events The coordinate cellular response to insulin-like growth factor-I (IGF-I) and insulin-like growth factor-binding protein-2 (IGFBP-2) is regulated through vimentin binding to receptor tyrosine phosphatase β (RPTPβ)Association between height and malignancy among children in the north of Iran.Inhibition of IGF1-R overcomes IGFBP7-induced chemotherapy resistance in T-ALL.Homeobox D10 gene, a candidate tumor suppressor, is downregulated through promoter hypermethylation and associated with gastric carcinogenesis.The insulin-like growth factor system in chronic kidney disease: Pathophysiology and therapeutic opportunities.Insulin-like growth factor-binding protein-7 (IGFBP7): a promising gene therapeutic for hepatocellular carcinoma (HCC).Insulin-like growth factor binding protein-3 inhibits monocyte adhesion to retinal endothelial cells in high glucose conditions.Insulin-like growth factor binding protein-3 (IGFBP-3): Novel ligands mediate unexpected functions.Emerging role of insulin-like growth factor-binding protein 7 in hepatocellular carcinoma.Insulin-like growth factor: current concepts and new developments in cancer therapy.Prohibitin-2 binding modulates insulin-like growth factor-binding protein-6 (IGFBP-6)-induced rhabdomyosarcoma cell migration.IL-13Rα2 uses TMEM219 in chitinase 3-like-1-induced signalling and effector responses.Insulin-like growth factor binding protein-3 links obesity and breast cancer progression.Signalling pathways of insulin-like growth factors (IGFs) and IGF binding protein-3.Importance of metabolic changes induced by chemotherapy on prognosis of early-stage breast cancer patients: a review of potential mechanisms.Insulin-like growth factor-binding protein-6 and cancer.Role of insulin-like growth factor-binding proteins in the pathophysiology and tumorigenesis of gastroesophageal cancers.Novel transcription-induced fusion RNAs in prostate cancer.Connecting myelin-related and synaptic dysfunction in schizophrenia with SNP-rich gene expression hubs.Insulin-like growth factor binding protein-3 enhances etoposide-induced cell growth inhibition by suppressing the NF-κB activity in gastric cancer cells.IGF binding protein-3 mediates stress-induced apoptosis in non-transformed mammary epithelial cells.IGFBP7 reduces breast tumor growth by induction of senescence and apoptosis pathways.Suppression of IGF binding protein-3 by palmitate promotes hepatic inflammatory responses.Role of insulin-like growth factor binding protein-3 in 1, 25-dihydroxyvitamin-d 3 -induced breast cancer cell apoptosis.Intrinsic, Pro-Apoptotic Effects of IGFBP-3 on Breast Cancer Cells are Reversible: Involvement of PKA, Rho, and Ceramide.

P2860

ccf31875eedb44d2204a5a2d1467d6e01591ce0d cfdbbd3f0dc2423c41952fc427a94981a4423766

P248

Q26798408-0634A7AC-C844-4ACD-A74C-8DD823BE8C2C Q27013698-5E4C094A-F62B-456D-B52D-40F89FCED195 Q28237971-9B364A78-1AD5-412E-AF43-D26F626316A5 Q30235013-E58E5D4D-83B5-45D1-97A9-1BE2ADD4B197 Q33632210-47FAB1EB-6BE2-4905-89A0-F346A79E272B Q33685277-8F509DF6-7992-45D1-9FCC-6D2234B4106A Q33756365-456DC5C2-96A7-4DA5-9E54-9E7DED74A0AF Q34172625-DED0983A-3150-4586-8493-C8416A1A0C5E Q34219109-BF8D5F42-9F72-437C-B269-1722BA9326F8 Q34335696-9531C532-425E-46C6-9215-EC258BA3277A Q34576044-32993846-8066-4410-82C7-BD0EE04E5B2B Q34805398-1C819691-C12E-4B9B-A8FF-BA569EE03154 Q34979016-3A026F2C-8129-4148-9613-77746F989986 Q35187561-74E350F5-36A3-4B23-9E7B-D1641FD3FAF7 Q35197405-0A435A48-B6D2-452C-B014-882AA8985F04 Q35561072-C47F6B9F-CFF9-433A-BA0D-F883E4B0939B Q35763352-8E7376EF-CF51-4045-B4AC-886988D8C50E Q35801047-DDE890D3-7B6F-432D-8922-E93E49D8D204 Q35973274-F1C67CB3-6E49-4A8A-91D0-5419A302CCA7 Q36468522-8E77126C-782E-427F-BA22-A0C001230F85 Q36740292-6C5A8C53-8B73-45E0-8C15-9FAA14DE7081 Q36766116-CA489FEF-AF8F-4F00-8872-5D6DA3CDE8F5 Q37004744-A676D665-3AF3-49BA-827A-FF2FD70955AF Q37031704-2D941A73-C3F4-4AD7-886A-0CD8EB95AD24 Q37047067-1DB9D7C7-E73F-4BB3-A638-252A75704DD2 Q37226250-299C0D66-204A-4D08-94B9-1BC410416F35 Q37264739-6D345ABB-84E3-495E-A229-BA464DA8246E Q37688258-4BF7920C-9E87-476A-959E-E7B048EF1AAD Q37927102-10D3D837-AFDF-4A28-861F-C9B1E7804CD8 Q37963505-94114662-8A4E-4AEA-8D60-55BC8E367D0D Q38057775-E8A0335D-8743-40A2-9FBD-EDB20C0DA540 Q38586626-D96C4D5A-E922-454D-BBF3-A6E977E031E4 Q38806903-4E25A5FE-A159-4C58-9AA6-C07DA45B3E1E Q38850829-1F306E1B-C8CC-4A23-88BE-5FF1F1B9D2C9 Q38911672-3A1D4F7E-1E1A-4F8B-9B55-85C69A0AAA41 Q39285362-EDA504BC-D4DD-4E89-875E-4FBF953A2463 Q39458425-183B15D8-ABF9-4928-AF23-0D1B084D54FD Q39461923-6CA39FAE-CD63-4C9F-9747-F8638867AD99 Q40643683-80DE447F-3A7B-45A5-B31B-903F565CA364 Q42175059-336727B2-9E1E-4208-A4B3-97C5C2B3AAD4

P2860

Identification of a novel cell death receptor mediating IGFBP-3-induced anti-tumor effects in breast and prostate cancer

http://www.wikidata.org/entity/Q24604176

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Identification of a novel cell ...... in breast and prostate cancer

@ast

Identification of a novel cell ...... in breast and prostate cancer

@en

Identification of a novel cell ...... in breast and prostate cancer

@nl

type

label

Identification of a novel cell ...... in breast and prostate cancer

@ast

Identification of a novel cell ...... in breast and prostate cancer

@en

Identification of a novel cell ...... in breast and prostate cancer

@nl

prefLabel

Identification of a novel cell ...... in breast and prostate cancer

@ast

Identification of a novel cell ...... in breast and prostate cancer

@en

Identification of a novel cell ...... in breast and prostate cancer

@nl

P1433

Q24604176-3798C84E-9C5D-4BF5-91D2-B8EAE5A0193A

P1476

Q24604176-D0F62A6E-686E-4B31-939D-BCDCFA96645C

P2093

Q24604176-2BD71D82-1695-4EB8-80C1-121F68312119

Q24604176-2CE7C981-B45C-464B-8B7C-D97CB823A64E

Q24604176-30016C2D-9E7B-4E09-9DD7-354BB07FBFFC

Q24604176-4DB16B27-323E-4A27-9681-FAB0FEBE33F6

Q24604176-4DD332F2-516D-45ED-A0CA-FBAE773483C5

Q24604176-57BE81BA-04D1-41FD-8E4C-6CD24F9D1C22

Q24604176-5D0B681B-C30D-44E6-BEE0-3BCAD937A828

Q24604176-63B7A48C-8CDD-44BA-B2FE-1C2AE98E8A4C

Q24604176-84496AC0-C308-4900-9EB8-4BA930D9B55D

Q24604176-92F7D235-9CB3-48B3-B8EA-98B2466E3E4E

P2860

Q24604176-0327B106-654B-4731-8E48-43D479285E4A

Q24604176-08A5506B-AE1F-4E53-B85A-7F582DE781D1

Q24604176-155E639A-93B7-4594-9586-AD8DE10714D2

Q24604176-15FCD46F-4B58-4DB1-89D3-103AE20E75B5

Q24604176-2274230E-2FD1-4465-BE72-3B8FA9117387

Q24604176-297E038D-2EC1-409C-B605-5D84FB76DE5B

Q24604176-2A23D8AE-628F-483E-B530-969FEDC3414A

Q24604176-4194FB7F-B7A3-4856-91EE-6340648328F0

Q24604176-4AE56B99-7352-4D59-9AC2-50D1899F3A53

Q24604176-5186948D-AFC1-491D-A693-D5904F3F88DA

P304

Q24604176-0601CD66-4679-4C4D-938D-A884EAE30807

P31

Q24604176-DDCC3D57-318D-4EFB-8CB3-B05127E46BE5

P3181

Q24604176-7D4E4C94-82D9-4E02-A2BC-B09CB71BD24A

P356

Q24604176-299666E3-612D-4C67-9AB1-0C44EBA9C93C

P407

Q24604176-FFAB1C86-322E-4CE9-B12F-BBBCAE660298

P433

Q24604176-7A82EEDF-CD47-46FB-85A0-5A18B28E601D

P478

Q24604176-7625591F-03CC-4A47-ADE6-8A1731EF1D09

P577

Q24604176-74627788-FD0F-4773-9627-2B57ED7AB4CA

P698

Q24604176-2ABD8B2E-F096-48E9-BD39-DE705B003A2A

P921

Q24604176-94D7145B-B733-415C-BDCE-5FC84818CB6E

P932

Q24604176-C17F7464-D853-440C-AABA-8A6CE2C11BC7

P3181

P356

JBC.M110.122226

P1433

Journal of Biological Chemistry

P1476

Identification of a novel cell ...... in breast and prostate cancer

@en

P2093

Aki Mikami

http://www.w3.org/2001/XMLSchema#string

Amanda E Garza

http://www.w3.org/2001/XMLSchema#string

Angela R Ingermann

http://www.w3.org/2001/XMLSchema#string

Dae-Yeol Lee

http://www.w3.org/2001/XMLSchema#string

Ho-Seong Kim

http://www.w3.org/2001/XMLSchema#string

Jinfeng Han

http://www.w3.org/2001/XMLSchema#string

Joy L Ware

http://www.w3.org/2001/XMLSchema#string

Lathika Mohanraj

http://www.w3.org/2001/XMLSchema#string

Lingbo Fan

http://www.w3.org/2001/XMLSchema#string

Michael Idowu

http://www.w3.org/2001/XMLSchema#string

P2860

Interaction between the Alzheimer's survival peptide humanin and insulin-like growth factor-binding protein 3 regulates cell survival and apoptosis

Insulin-like growth factor-binding protein-3 modulates expression of Bax and Bcl-2 and potentiates p53-independent radiation-induced apoptosis in human breast cancer cells

Direct functional interactions between insulin-like growth factor-binding protein-3 and retinoid X receptor-alpha regulate transcriptional signaling and apoptosis

The insulin-like growth factor-binding protein (IGFBP) superfamily

Cellular growth inhibition by IGFBP-3 and TGF-beta1 requires LRP-1

Transferrin is an insulin-like growth factor-binding protein-3 binding protein

Cellular internalization of insulin-like growth factor binding protein-3: distinct endocytic pathways facilitate re-uptake and nuclear localization

Cellular actions of the insulin-like growth factor binding proteins

Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions

Unoccupied alpha(v)beta3 integrin regulates osteoclast apoptosis by transmitting a positive death signal

P304

30233-46

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3514418

http://www.w3.org/2001/XMLSchema#string

P356

10.1074/JBC.M110.122226

http://www.w3.org/2001/XMLSchema#string

P407

P433

39

http://www.w3.org/2001/XMLSchema#string

P478

285

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20353938

http://www.w3.org/2001/XMLSchema#string

P921

P932

2943278

http://www.w3.org/2001/XMLSchema#string